PerturbAI
PrivateLast Round
Pre Seed
Sep 1, 2025
Company Overview
PerturbAI operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Pre Seed round in September 2025.
PerturbAI is a biotechnology company that develops an AI-enabled drug discovery platform by combining large-scale in vivo CRISPR perturbation with artificial intelligence to map causal biological relationships.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Foundation
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PerturbAI Comparables
Compare PerturbAI with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Synlico Inc. | 87% | |
| Algen Biotechnologies | 84% | |
| Myllia Biotechnology | 84% |
For institutional investors. Book with your work email.
PerturbAI Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2025
Completed a Pre Seed funding round.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withOct 21, 2026
In California on Oct 21st '26, PerturbAI and OpenAI, Inc. report a year-long collaboration that jointly develops AI reasoning agents to help scientists interpret complex biological data for drug discovery.
- is_developingOct 21, 2026
Perturb and OpenAI have jointly developed AI reasoning agents that analyze cellular responses, search scientific literature, and connect experimental results with biological knowledge to help scientists interpret complex data for drug discovery.
- launchesOct 21, 2026
PerturbAI unveils first-of-its-kind AI reasoning agents with OpenAI in California on Oct 21st '26 to help scientists interpret experimental data, connect findings with scientific literature, and identify testable biomedical hypotheses.
- launchesOct 21, 2026
PerturbAI unveils its drug discovery engine in Mar '26 to map genomic cause and effect in living organisms and generate prioritized drug targets.
- partners_withOct 20, 2026
PerturbAI, Scripps Research Translational Institute, and OpenAI collaborate to deploy thousands of AI agents that analyze millions of mouse brain cells and identify promising research leads related to brain diseases.
For institutional investors. Book with your work email.
PerturbAI Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PerturbAI's valuation, stock price, and market status.
Is PerturbAI a public or private company?
PerturbAI is a private company.
What is the current stock price of PerturbAI?
PerturbAI is a private company, so its shares have no public market price. Caplight tracks PerturbAI's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PerturbAI worth (valuation)?
Valuation information for PerturbAI is not publicly available.
Can I buy PerturbAI stock?
PerturbAI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PerturbAI's last funding round?
PerturbAI's most recent funding round was Pre Seed on September 1, 2025.
Who are the main investors in PerturbAI?
Investor information for PerturbAI is not publicly disclosed.
Will PerturbAI IPO soon?
No public IPO plans have been announced for PerturbAI.
How can I track PerturbAI secondary market activity?
Caplight tracks bids, offers, and trades in PerturbAI's shares on secondary markets.